Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
results tags : Pharm-country save search
Quantum-Si to Report First Quarter 2024 Financial Results on May 9, 2024
Published: 2024-04-18 (Crawled : 00:00) - biospace.com/
QSI | $1.57 3.97% 3.82% 730K
|
Professional, Scientific, and T...
|
| O: -0.65%
H: 0.0%
C: 0.0%
first report financial results
KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024
Published: 2024-04-17 (Crawled : 12:00) - biospace.com/
KRMD | $2.06 0.0% 59K
|
Health Technology
|
| O: -0.94%
H: 4.29%
C: 0.95%
first report medical financial results
Legend Biotech to Host Investor Conference Call on First Quarter 2024 Results
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
LEGN | $46.14 -2.08% -2.12% 1.2M
|
Health Technology
|
| O: 0.02%
H: 0.22%
C: -0.88%
first conference biotech results
PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
PTCT | $25.32 2.55% 2.49% 3.9M
|
Health Technology
|
| O: 2.01%
H: 1.35%
C: -0.18%
first conference therapeutics financial results
Pfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO® in Adults Aged 18 to 59 at Increased Risk for RSV Disease
Published: 2024-04-09 (Crawled : 12:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.73%
H: 2.49%
C: 0.11%
abrysvo disease positive risk for rsv results study
AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture
Published: 2024-04-04 (Crawled : 19:00) - biospace.com/
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
|
| O: 0.61%
H: 0.0%
C: 0.0%
ANGO | $6.26 2.29% 2.24% 480K
|
Health Technology
|
| O: 1.43%
H: 12.5%
C: 0.0%
year financial
NRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
NRXP 1 d | $3.08 1.99% 1.95% 230K
|
Manufacturing
|
| O: 895.97%
H: 14.34%
C: 11.7%
business year update pharmaceuticals financial results
Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
SBFM | $1.765 -46.84% -88.1% 11M
|
Professional, Scientific, and T...
|
| O: 83.97%
H: 18.6%
C: -4.31%
year biopharma results
Context Therapeutics Reports Full Year 2023 Operating and Financial Results
Published: 2024-03-21 (Crawled : 12:00) - biospace.com/
CNTX | $1.39 -1.42% -1.44% 5.7K
|
Health Technology
|
| O: 0.87%
H: 6.78%
C: -7.76%
year therapeutics financial results
Soligenix Announces Recent Accomplishments and Year End 2023 Financial Results
Published: 2024-03-15 (Crawled : 13:00) - biospace.com/
SNGX | $0.4233 -2.76% -2.83% 1M
|
Health Technology
|
| O: 0.5%
H: 7.98%
C: -3.13%
year financial results
KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance
Published: 2024-03-13 (Crawled : 23:00) - biospace.com/
KRMD | $2.06 0.0% 59K
|
Health Technology
|
| O: 0.95%
H: 0.94%
C: 0.0%
year medical financial
Lexeo Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Published: 2024-03-11 (Crawled : 16:00) - biospace.com/
LXEO | $11.995 -0.62% -0.63% 87K
|
|
| O: 6.87%
H: 0.0%
C: -10.39%
year therapeutics financial results
Savara Reports Fourth Quarter/Year-End 2023 Financial Results and Provides Business Update
Published: 2024-03-07 (Crawled : 23:00) - biospace.com/
SVRA | $4.81 0.42% 0.42% 880K
|
Health Technology
|
| O: 1.29%
H: 2.09%
C: 1.82%
business update financial results
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024
Published: 2024-03-06 (Crawled : 22:00) - biospace.com/
CSBR | $5.1 0.69% 0.69% 960
|
Health Technology
|
| O: -0.71%
H: 0.71%
C: -0.32%
financial results
UroGen Pharma to Report Fourth Quarter and Full-Year 2023 Financial Results on Thursday, March 14, 2024
Published: 2024-03-04 (Crawled : 13:30) - biospace.com/
URGN | $13.78 -3.37% -3.48% 390K
|
Health Technology
|
| O: 0.73%
H: 4.08%
C: 2.91%
pharma report financial results
VYNE Therapeutics to Present Results of the Phase 1b Trial for VYN201 at the 2024 Global Vitiligo Foundation Annual Scientific Symposium
Published: 2024-02-27 (Crawled : 14:30) - biospace.com/
VYNE | $2.285 -0.65% -0.66% 19K
|
Health Technology
|
| O: -0.43%
H: 1.71%
C: 1.28%
vyn201 symposium global trial therapeutics results
KORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024
Published: 2024-02-21 (Crawled : 19:00) - biospace.com/
KRMD | $2.06 0.0% 59K
|
Health Technology
|
| O: -0.43%
H: 1.86%
C: -1.48%
report year medical financial results
Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results
Published: 2024-02-08 (Crawled : 00:00) - biospace.com/
APDN | $0.3396 0.59% 0.59% 85K
|
Commercial Services
|
| O: 5.0%
H: 0.02%
C: -4.76%
first year dna financial results
Insmed to Host Fourth-Quarter and Full Year 2023 Financial Results Conference Call on Thursday, February 22, 2024
Published: 2024-02-08 (Crawled : 00:00) - biospace.com/
INSM | $24.4 -1.61% -1.64% 5.5M
|
Health Technology
|
| O: -0.17%
H: 0.21%
C: -1.28%
conference year financial results
Petros Pharmaceuticals Demonstrates Positive Results Following Successful Completion of Initial Cohort of Phase 2 Equivalent Self-Selection Study for STENDRA (avanafil) Rx-to-OTC Switch
Published: 2024-01-17 (Crawled : 14:30) - biospace.com/
PTPI | $0.6849 -1.86% -1.9% 150K
|
|
| O: 21.31%
H: 5.41%
C: -19.59%
stendra positive pharmaceuticals results study
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.